Table 3 Frequency of NPS and subgroups, ADL functioning and cognition among patients with diagnosed dementia
Users of anti-dementia drugs | Non-users of anti-dementia drugs | P-value* | |
|---|---|---|---|
n = 791 | n = 351 | ||
Frequency of NPS, n (%) | |||
None | 320 (40.4) | 162 (46.1) | 0.074 |
One symptom | 252 (31.8) | 114 (32.5) | 0.867 |
Two to three symptoms | 171 (21.6) | 55 (15.7) | 0.016 |
Four or more symptoms | 48 (6.1) | 20 (5.7) | 0.771 |
Any NPS, n (%) | 471 (59.5) | 189 (53.8) | 0.771 |
Subgroups, n (%) | |||
Hyperactivity | 264 (33.3) | 116 (33.0) | |
Psychosis | 105 (13.2) | 36 (10.3) | |
Mood symptoms and apathy | 299 (37.6) | 90 (25.6) | |
ADL score, mean (SD) | 58.0 (31.5) | 29.8 (34.5) | <0.001 |
MMSE, mean (SD) | 16.0 (6.6) | 14.7 (8.0) | 0.011 |